Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sustained increase of paediatric invasive Streptococcus pyogenes infections dominated by M1UK and diverse emm12 isolates, Portugal, September 2022 to May 2023.
Gouveia C, Bajanca-Lavado MP, Mamede R, Araújo Carvalho A, Rodrigues F, Melo-Cristino J, Ramirez M, Friães A; Portuguese Group for the Study of Streptococcal Infections; Portuguese Study Group of Pediatric Invasive Streptococcal Disease; Portuguese Study Group of Paediatric Invasive Streptococcal Disease. Gouveia C, et al. Euro Surveill. 2023 Sep;28(36):2300427. doi: 10.2807/1560-7917.ES.2023.28.36.2300427. Euro Surveill. 2023. PMID: 37676143 Free PMC article.
AIMSurv: First pan-European harmonized surveillance of Aedes invasive mosquito species of relevance for human vector-borne diseases.
Miranda MÁ, Barceló C, Arnoldi D, Augsten X, Bakran-Lebl K, Balatsos G, Bengoa M, Bindler P, Boršová K, Bourquia M, Bravo-Barriga D, Čabanová V, Caputo B, Christou M, Delacour S, Eritja R, Fassi-Fihri O, Ferraguti M, Flacio E, Frontera E, Fuehrer HP, García-Pérez AL, Georgiades P, Gewehr S, Goiri F, González MA, Gschwind M, Gutiérrez-López R, Horváth C, Ibáñez-Justicia A, Jani V, Kadriaj P, Kalan K, Kavran M, Klobucar A, Kurucz K, Lucientes J, Lühken R, Magallanes S, Marini G, Martinou AF, Michelutti A, Mihalca AD, Montalvo T, Montarsi F, Mourelatos S, Muja-Bajraktari N, Müller P, Notarides G, Osório HC, Oteo JA, Oter K, Pajović I, Palmer JRB, Petrinic S, Răileanu C, Ries C, Rogozi E, Ruiz-Arrondo I, Sanpera-Calbet I, Sekulić N, Sevim K, Sherifi K, Silaghi C, Silva M, Sokolovska N, Soltész Z, Sulesco T, Šušnjar J, Teekema S, Valsecchi A, Vasquez MI, Velo E, Michaelakis A, Wint W, Petrić D, Schaffner F, Della Torre A; Consortium AIM-COST/AIM-Surv. Miranda MÁ, et al. GigaByte. 2022 May 31;2022:gigabyte57. doi: 10.46471/gigabyte.57. eCollection 2022. GigaByte. 2022. PMID: 36824512 Free PMC article.
Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma: Results from a Proof-of-Concept, Phase Ib Study.
Abdul Razak AR, Bauer S, Suarez C, Lin CC, Quek R, Hütter-Krönke ML, Cubedo R, Ferretti S, Guerreiro N, Jullion A, Orlando EJ, Clementi G, Sand Dejmek J, Halilovic E, Fabre C, Blay JY, Italiano A. Abdul Razak AR, et al. Among authors: guerreiro n. Clin Cancer Res. 2022 Mar 15;28(6):1087-1097. doi: 10.1158/1078-0432.CCR-21-1291. Clin Cancer Res. 2022. PMID: 34921024 Clinical Trial.
Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia.
Stein EM, DeAngelo DJ, Chromik J, Chatterjee M, Bauer S, Lin CC, Suarez C, de Vos F, Steeghs N, Cassier PA, Tai D, Kiladjian JJ, Yamamoto N, Mous R, Esteve J, Minami H, Ferretti S, Guerreiro N, Meille C, Radhakrishnan R, Pereira B, Mariconti L, Halilovic E, Fabre C, Carpio C. Stein EM, et al. Among authors: guerreiro n. Clin Cancer Res. 2022 Mar 1;28(5):870-881. doi: 10.1158/1078-0432.CCR-21-1295. Clin Cancer Res. 2022. PMID: 34862243 Free PMC article. Clinical Trial.
A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer.
Kuemmel S, Campone M, Loirat D, Lopez RL, Beck JT, De Laurentiis M, Im SA, Kim SB, Kwong A, Steger GG, Adelantado EZ, Duhoux FP, Greil R, Kuter I, Lu YS, Tibau A, Özgüroğlu M, Scholz CW, Singer CF, Vega E, Wimberger P, Zamagni C, Couillebault XM, Fan L, Guerreiro N, Mataraza J, Sand-Dejmek J, Chan A. Kuemmel S, et al. Among authors: guerreiro n. Clin Cancer Res. 2022 Jan 1;28(1):106-115. doi: 10.1158/1078-0432.CCR-20-3955. Epub 2021 Oct 6. Clin Cancer Res. 2022. PMID: 34615719 Clinical Trial.
Pharmacokinetic-pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies.
Bauer S, Demetri GD, Halilovic E, Dummer R, Meille C, Tan DSW, Guerreiro N, Jullion A, Ferretti S, Jeay S, Van Bree L, Hourcade-Potelleret F, Wuerthner JU, Fabre C, Cassier PA. Bauer S, et al. Among authors: guerreiro n. Br J Cancer. 2021 Aug;125(5):687-698. doi: 10.1038/s41416-021-01444-4. Epub 2021 Jun 17. Br J Cancer. 2021. PMID: 34140638 Free PMC article. Clinical Trial.
A Practical Guide to Genitourinary Trauma.
Leite C, Guerreiro N, Camerin GR, Alves I, Oliveira B, Nastri M, Jayanthi SK, Horvat JV, Cavalcante Viana PC, Horvat N. Leite C, et al. Among authors: guerreiro n. Radiographics. 2021 Jan-Feb;41(1):96-97. doi: 10.1148/rg.2021200110. Radiographics. 2021. PMID: 33411613 No abstract available.
42 results